The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections. (2022)

First Author: Zhu J
Attributed to:  App Guarden: Resilient Application Stores funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-3-319-58469-0_21

PubMed Identifier: 36407474

Publication URI: http://europepmc.org/abstract/MED/36407474

Type: Journal Article/Review

Volume: 2

Parent Publication: Intensive care research

Issue: 3-4

ISSN: 2666-9862